Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Dec;32(6):697-704.

Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green

Affiliations
Clinical Trial

Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green

P A Soons et al. Br J Clin Pharmacol. 1991 Dec.

Abstract

1. The applicability of a continuous infusion of indocyanine green (ICG) to detect changes in apparent hepatic blood flow (HBF) was investigated in six healthy subjects. 2. High-performance liquid chromatography was used to measure ICG concentrations, and the effect of intravenous propranolol (10 mg in 10 min) on HBF was investigated. 3. During 150 min infusions of ICG (1.0 mg min-1) steady-state was reached within about 30 min and thereafter the plasma dye concentration remained essentially constant until the end of infusion. 4. Blood clearance (CLb) of ICG (15.9 +/- 2.2 ml min-1 kg-1; mean +/- s.d.), calculated as infusion rate/blood dye concentration over three time periods (30-50, 80-100 and 130-150 min) during the 150 min infusion, was not different from that obtained with three 1-min infusions (0.5 mg kg-1) administered at corresponding times of the day (CLb = 14.0 +/- 2.2 ml min-1 kg-1, P = 0.06). 5. The pharmacokinetics of ICG were shown to be linear up to plasma concentrations of at least 3 micrograms ml-1 using variable infusion rates (0.5, 1.0 and 2.0 mg min-1). 6. Propranolol had little effect on ICG concentrations during continuous infusion. The AUC of ICG from the start of propranolol infusion up to 125 min thereafter was increased by 12% +/- 17% (P = 0.21) compared with placebo.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1962 May;41:1169-79 - PubMed
    1. JAMA. 1967 Apr 17;200(3):236-40 - PubMed
    1. Clin Sci (Lond). 1991 Feb;80(2):155-60 - PubMed
    1. J Clin Pharmacol. 1990 Oct;30(10):922-9 - PubMed
    1. Pharmacol Rev. 1987 Mar;39(1):1-47 - PubMed

Publication types

LinkOut - more resources